Bayer Sues Mylan Over Generic Yaz

Law360 (April 20, 2011, 6:05 PM EDT) -- Bayer AG filed a patent infringement suit Monday in Nevada federal court against Mylan Pharmaceuticals Inc. over the generics maker’s bid to sell a version of oral contraceptive Yaz in the U.S.

Continuing its efforts to block a generic version of Yaz from hitting the U.S. market, Bayer alleges that Mylan’s proposed product would infringe one or more claims of U.S. Patent Number RE37,564.

Yaz, a combination of drospirenone and ethinyl estradiol, is marketed as the only oral contraceptive also approved by the FDA to treat...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.